Literature DB >> 32602434

Population Screening for Urine Antigens to Detect Asymptomatic Subarachnoid Neurocysticercosis: A Pilot Study in Northern Peru.

Ellen McCleery1, Samantha E Allen2, Luz Maria Moyano3, Ricardo Gamboa3, Percy Vilchez3, Claudio Muro3, Yesenia Castillo4, Pierre Dorny5, Hector H Garcia3,4, Seth E O'Neal2,3,6.   

Abstract

Subarachnoid neurocysticercosis (SANCC) is a severe and progressive brain infection with Taenia solium. We performed a pilot study of noninvasive screening for SANCC in two endemic villages in northern Peru using a urine antigen screen followed by brain magnetic resonance imaging for participants with elevated levels of antigen. Among the 978 participants screened, we identified eight individuals with SANCC, many of whom were asymptomatic. This represents a minimum prevalence of 0.8% of SANCC, a level higher than expected based on prior studies, and a positive predictive value of 62% for our novel urine screening test. Future studies should confirm whether early detection and management improve clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32602434      PMCID: PMC7470589          DOI: 10.4269/ajtmh.20-0196

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

Review 1.  Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease.

Authors:  Agnès Fleury; Roger Carrillo-Mezo; Ana Flisser; Edda Sciutto; Teresa Corona
Journal:  Expert Rev Anti Infect Ther       Date:  2011-01       Impact factor: 5.091

2.  A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis.

Authors:  J R Brandt; S Geerts; R De Deken; V Kumar; F Ceulemans; L Brijs; N Falla
Journal:  Int J Parasitol       Date:  1992-07       Impact factor: 3.981

3.  Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery.

Authors:  Jefferson V Proaño; Jaime Torres-Corzo; Roberto Rodríguez-Della Vecchia; Gabriel Guizar-Sahagun; Leonardo Rangel-Castilla
Journal:  Childs Nerv Syst       Date:  2009-06-26       Impact factor: 1.475

4.  An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India.

Authors:  Kashi N Prasad; Avantika Verma; Sandeep Srivastava; Rakesh K Gupta; Chandra M Pandey; Vimal K Paliwal
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-07-20       Impact factor: 2.184

5.  Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.

Authors:  J V Proaño; I Madrazo; F Avelar; B López-Félix; G Díaz; I Grijalva
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis.

Authors:  Rosemarie Kelley; Duc H Duong; George E Locke
Journal:  Neurosurgery       Date:  2002-04       Impact factor: 4.654

7.  A prognostic classification of cerebral cysticercosis: therapeutic implications.

Authors:  B Estañol; T Corona; P Abad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

8.  Urine antigen detection for the diagnosis of human neurocysticercosis.

Authors:  Yesenia Castillo; Silvia Rodriguez; Hector H García; Jef Brandt; Anke Van Hul; Maria Silva; Richar Rodriguez-Hidalgo; Mylagritos Portocarrero; D Paolo Melendez; Armando E Gonzalez; Robert H Gilman; Pierre Dorny
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

9.  Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases.

Authors:  J Sotelo; C Marin
Journal:  J Neurosurg       Date:  1987-05       Impact factor: 5.115

10.  Natural History of Treated Subarachnoid Neurocysticercosis.

Authors:  Theodore E Nash; Elise M O'Connell; Dima A Hammoud; Lauren Wetzler; JeanAnne M Ware; Siddhartha Mahanty
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

View more
  2 in total

1.  Urine 1H-NMR Metabolomics to Discriminate Neurocysticercosis Patients from Healthy Controls: An Exploratory Study.

Authors:  Juan M Lopez; Vanessa E Leyva; Javier A Bustos; Erika Perez; Sofía Sanchez; Herbert Saavedra; Isidro Gonzales; Helena Maruenda; Hector H Garcia
Journal:  Am J Trop Med Hyg       Date:  2022-05-23       Impact factor: 3.707

2.  A recombinant monoclonal-based Taenia antigen assay that reflects disease activity in extra-parenchymal neurocysticercosis.

Authors:  Madelynn Corda; Joshua Sciurba; Jiana Blaha; Siddhartha Mahanty; Adriana Paredes; Hector H Garcia; Theodore E Nash; Thomas B Nutman; Elise M O'Connell
Journal:  PLoS Negl Trop Dis       Date:  2022-05-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.